Purpose of this Study
We are doing this study to find out if an experimental test for the detection of hepatocellular carcinoma (liver cancer) called Oncoguard® is a reliable and accurate means to detect the disease in its earliest stages.
Who Can Participate?
Eligibility
Adults ages 55+ who:
- Are diagnosed with liver cirrhosis
- Are scheduled to have routine liver ultrasounds for cancer surveillance
- Do not have any history of esophageal bleeding or mental confusion related to liver disease
- Have not had any form of active cancer in the past 5 years (some skin cancers are OK)
Age Range
55-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will:
- Have blood draws
- Have a CT scan within 30 days of your regularly scheduled liver ultrasound
- Give us permission to collect information about your liver health from your medical records
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma (HCC) Test in Subjects with Increased Risk
Principal Investigator
Cynthia
Moylan
Protocol Number
PRO00115210
NCT ID
NCT05064553
Phase
N/A
Enrollment Status
Open to Enrollment